8-KEarnings & ResultsExhibits & Filings

Edwards Lifesciences Corp 8-K Report, Financial Results (Oct 25, 2005)

Filed October 25, 2005For Securities:EW

Summary

This 8-K filing from Edwards Lifesciences Corporation (EW) on October 25, 2005, primarily serves to announce the company's financial results for the third quarter of 2005. The report contains a press release detailing these results, which is furnished under Item 2.02 and partially filed under the Securities Exchange Act. Investors should pay close attention to the full press release (Exhibit 99.1) for specific financial performance metrics, including revenue, earnings, and any commentary on the company's operational and financial condition during the period. The filing indicates that the press release contains detailed financial information for the third quarter of 2005. While the 8-K itself is brief, the attached press release is the critical document for understanding the company's performance. Investors should review this release for insights into sales trends, profitability, and any forward-looking statements or guidance provided by Edwards Lifesciences management. The Chief Financial Officer, Corinne H. Lyle, has signed off on the filing, underscoring the significance of the financial reporting.

Key Highlights

  • 1Edwards Lifesciences Corporation (EW) reported its third-quarter 2005 financial results on October 25, 2005, via an 8-K filing.
  • 2The primary purpose of the 8-K is to furnish a press release (Exhibit 99.1) detailing the company's Q3 2005 financial performance.
  • 3Specific Q3 2005 financial results are contained within the attached press release (Exhibit 99.1).
  • 4Parts of the furnished press release, specifically the first two paragraphs and pages 6-12, are deemed filed with the SEC.
  • 5The filing was signed by Corinne H. Lyle, Corporate Vice President, Chief Financial Officer and Treasurer, indicating official financial reporting.
  • 6Investors are directed to the press release for comprehensive details on the company's operations and financial condition for the third quarter.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce and report Edwards Lifesciences Corporation's financial results for the third quarter of 2005 through an attached press release.

The detailed financial results for the third quarter of 2005 are located in the press release attached as Exhibit 99.1 to this 8-K filing. Specific portions of this press release are considered filed with the SEC.

The report was signed by Corinne H. Lyle, who holds the positions of Corporate Vice President, Chief Financial Officer, and Treasurer at Edwards Lifesciences Corporation.

No, only the first two paragraphs of the press release and pages 6 through 12 are considered to be 'filed' under the Securities Exchange Act. The rest of the information furnished in the press release is not deemed filed.